Literature DB >> 1534508

Tetracycline administration increases collagen synthesis in osteoblasts of streptozotocin-induced diabetic rats: a quantitative autoradiographic study.

T Sasaki1, N S Ramamurthy, L M Golub.   

Abstract

Streptozotocin-induced, insulin-deficient diabetic rats were administrated either minocycline (MC) or a chemically modified non-antimicrobial tetracycline (CMT) by oral gavage for a 3-week period; untreated diabetic and nondiabetic rats served as controls. On day 21, all rats received an intravenous injection of 3H-proline followed by perfusion fixation with an aldehyde mixture at 20 minutes and 4 hours after isotope injection. The parietal bones of these rats were dissected and processed for quantitative electron microscopic autoradiography to study 3H-proline utilization by osteoblasts. At 20 minutes after 3H-proline injection, radioprecursor was incorporated by the Golgi-RER system of the osteoblasts in the periosteal surface of the control rats. At the 4-hour time period, most of the label was present over the collagen fibers of the osteoid. In contrast, the flattened bone-lining cells in the untreated diabetic rats showed minimal uptake (20 minutes) and secretion (4 hours) of labeled proline. In both MC and CMT-treated diabetic rats, the radioprecursor was localized in the osteoblasts and osteoid matrix in a pattern similar to that seen in the control rats at both 20 minutes and 4 hours after isotope injection. Labeling of the osteoid by the radioprecursor was greater as a result of CMT treatment than during minocycline treatment. These results suggest that the diabetes-induced suppression of synthesis and secretion of protein (presumably collagen and its precursor) by osteoblasts can be restored to near-normal levels by administration of tetracycline(s) and that this effect is mediated by a non-antimicrobial property of these antibiotics.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1534508     DOI: 10.1007/bf00296771

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  27 in total

1.  Alloxan diabetes and reduced bone density in rat mandible.

Authors:  N S Ramamurthy; E J Zebrowski; C Baker; L M Golub
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1973-05

2.  Immunohistochemical localization of procollagens. III. Type I procollagen antigenicity in osteoblasts and prebone (osteoid).

Authors:  G M Wright; C P Leblond
Journal:  J Histochem Cytochem       Date:  1981-07       Impact factor: 2.479

3.  Correction of abnormal bone and mineral metabolism in chronic streptozotocin-induced diabetes mellitus in the rat by insulin therapy.

Authors:  S Hough; L V Avioli; M A Bergfeld; M D Fallon; E Slatopolsky; S L Teitelbaum
Journal:  Endocrinology       Date:  1981-06       Impact factor: 4.736

4.  Minocycline reduces gingival collagenolytic activity during diabetes. Preliminary observations and a proposed new mechanism of action.

Authors:  L M Golub; H M Lee; G Lehrer; A Nemiroff; T F McNamara; R Kaplan; N S Ramamurthy
Journal:  J Periodontal Res       Date:  1983-09       Impact factor: 4.419

5.  Decreased cortical thickness & osteopenia in children with diabetes mellitus.

Authors:  J V Santiago; W H McAlister; S K Ratzan; Y Bussman; M W Haymond; G Shackelford; V V Weldon
Journal:  J Clin Endocrinol Metab       Date:  1977-10       Impact factor: 5.958

6.  Abnormalities in the biosynthesis of cartilage and bone proteoglycans in experimental diabetes.

Authors:  R E Weiss; A H Gorn; M E Nimni
Journal:  Diabetes       Date:  1981-08       Impact factor: 9.461

7.  Bone mass and bone density in maturity-type diabetics measured by the 125I photon-absorption technique.

Authors:  I De Leeuw; R Abs
Journal:  Diabetes       Date:  1977-12       Impact factor: 9.461

8.  Influence of experimental diabetes and insulin on matrix-induced cartilage and bone differentiation.

Authors:  R E Weiss; A H Reddi
Journal:  Am J Physiol       Date:  1980-03

9.  Diabetes stimulates procollagen degradation in rat tendon in vitro.

Authors:  M K Leung; G A Folkes; N S Ramamurthy; M Schneir; L M Golub
Journal:  Biochim Biophys Acta       Date:  1986-02-19

10.  Bone loss in diabetes: effects of metabolic state.

Authors:  P McNair; S Madsbad; C Christiansen; M S Christensen; O K Faber; C Binder; I Transbøl
Journal:  Diabetologia       Date:  1979-11       Impact factor: 10.122

View more
  11 in total

Review 1.  Using tetracyclines to treat osteoporotic/osteopenic bone loss: from the basic science laboratory to the clinic.

Authors:  Jeffrey B Payne; Lorne M Golub
Journal:  Pharmacol Res       Date:  2010-10-16       Impact factor: 7.658

Review 2.  Tetracyclines and bone: Unclear actions with potentially lasting effects.

Authors:  Amy J Warner; Jessica D Hathaway-Schrader; Rena Lubker; Christopher Davies; Chad M Novince
Journal:  Bone       Date:  2022-03-03       Impact factor: 4.626

3.  Subantimicrobial dose doxycycline effects on alveolar bone loss in post-menopausal women.

Authors:  Jeffrey B Payne; Julie A Stoner; Pirkka V Nummikoski; Richard A Reinhardt; Arthur D Goren; Mark S Wolff; Hsi-Ming Lee; James C Lynch; Robert Valente; Lorne M Golub
Journal:  J Clin Periodontol       Date:  2007-09       Impact factor: 8.728

4.  Subantimicrobial-dose doxycycline modulates gingival crevicular fluid biomarkers of periodontitis in postmenopausal osteopenic women.

Authors:  Lorne M Golub; Hsi Ming Lee; Julie A Stoner; Timo Sorsa; Richard A Reinhardt; Mark S Wolff; Maria E Ryan; Pirkka V Nummikoski; Jeffrey B Payne
Journal:  J Periodontol       Date:  2008-08       Impact factor: 6.993

5.  Oral disease burden in Northern Manhattan patients with diabetes mellitus.

Authors:  Evanthia Lalla; David B Park; Panos N Papapanou; Ira B Lamster
Journal:  Am J Public Health       Date:  2004-05       Impact factor: 9.308

6.  Sustained and localized in vitro release of BMP-2/7, RANKL, and tetracycline from FlexBone, an elastomeric osteoconductive bone substitute.

Authors:  Jianwen Xu; Xinning Li; Jane B Lian; David C Ayers; Jie Song
Journal:  J Orthop Res       Date:  2009-10       Impact factor: 3.494

7.  Oral disease burden in northern Manhattan patients with diabetes mellitus.

Authors:  Evanthia Lalla; David B Park; Panos N Papapanou; Ira B Lamster
Journal:  Am J Public Health       Date:  2008-09       Impact factor: 9.308

8.  Effect of tetracyclines which have metalloproteinase inhibitory capacity on basal and heparin-stimulated bone resorption by chick osteoclasts.

Authors:  M H Chowdhury; S A Moak; B R Rifkin; R A Greenwald
Journal:  Agents Actions       Date:  1993-09

9.  Effects of long-term doxycycline on bone quality and strength in diabetic male DBA/2J mice.

Authors:  John L Fowlkes; Jeffry S Nyman; R Clay Bunn; Gael E Cockrell; Elizabeth C Wahl; Mallikarjuna R Rettiganti; Charles K Lumpkin; Kathryn M Thrailkill
Journal:  Bone Rep       Date:  2015-01

10.  Non-antibacterial tetracycline formulations: clinical applications in dentistry and medicine.

Authors:  Ying Gu; Clay Walker; Maria E Ryan; Jeffrey B Payne; Lorne M Golub
Journal:  J Oral Microbiol       Date:  2012-10-12       Impact factor: 5.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.